Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-09-2021 | Cystic Fibrosis | Case report

Cotrimoxazole

Development of drug resistance: case report

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Wolter DJ, et al. Repeated isolation of an antibiotic-dependent and temperature-sensitive mutant of Pseudomonas aeruginosa from a cystic fibrosis patient. Journal of Antimicrobial Chemotherapy 76: 616-625, No. 3, 11 Feb 2021. Available from: URL: http://doi.org/10.1093/jac/dkaa482 Wolter DJ, et al. Repeated isolation of an antibiotic-dependent and temperature-sensitive mutant of Pseudomonas aeruginosa from a cystic fibrosis patient. Journal of Antimicrobial Chemotherapy 76: 616-625, No. 3, 11 Feb 2021. Available from: URL: http://​doi.​org/​10.​1093/​jac/​dkaa482
Metadata
Title
Cotrimoxazole
Development of drug resistance: case report
Publication date
01-09-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-02071-9

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Multiple drugs

Case report

Osimertinib

Case report

Rituximab

Case report

Multiple drugs